Infusion 51a is a modern impact investment fund that specializes in investing in public and private oncology companies. Their team combines financial expertise and operational talent to improve the prospects of these companies through various strategies. They focus on life sciences and medical technology in oncology, particularly precision medicine. Their value creation proposal includes consulting, strengthening management teams, restructuring boards of directors, optimizing capital structures, and improving branding and marketing. They also provide assistance with legal and intellectual property needs. Infusion 51a aims to disrupt the market, create unicorns, and make a positive impact on the world.